4//SEC Filing
ROBINSON MATTHEW K 4
Accession 0001104659-22-073102
CIK 0001472012other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:06 PM ET
Size
5.4 KB
Accession
0001104659-22-073102
Insider Transaction Report
Form 4
Immunome Inc.IMNM
ROBINSON MATTHEW K
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-16+35,000→ 35,000 totalExercise: $3.42Exp: 2032-06-16→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001934462
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 6:06 PM ET
- Size
- 5.4 KB